PremiumThe FlyMaravai Lifesciences appoints Bernd Brust as CEO TriLink BioTechnologies, Quantoom Biosciences sign license, supply agreement Maravai Lifesciences Holds Annual Shareholders Meeting PremiumRatingsCautious Outlook for Maravai Lifesciences Amid Profitability Challenges and Transitional Changes Maravai Lifesciences price target lowered to $2 from $3 at Baird Maravai LifeSciences Reports Q1 2025 Financial Results PremiumThe FlyMaravai Lifesciences price target lowered to $5 from $7 at Morgan Stanley Maravai LifeSciences Earnings Call: Growth Amid Challenges Biotech Alert: Searches spiking for these stocks today 
